Knight to Present at the Jefferies 2023 Healthcare Conference in New York City Pharmaceutical Investing
LUPKYNIS® Achieved Significantly Higher Renal Response in Lupus Nephritis Patients with High Proteinuria Compared to Patients Treated with MMF and Low Dose Steroids Alone Pharmaceutical Investing
OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease Pharmaceutical Investing
Aurinia Files Form S-8 to Register Shares Underlying Previously Disclosed Inducement Awards for Newly Hired Employees Pharmaceutical Investing
BriaCell Enters Definitive Arrangement Agreement for the Spin Out of BriaPro Therapeutics Corp. Pharmaceutical Investing
BriaCell Closes $4 Million Strategic Investment by Prevail Partners, LLC at US$8.63 per Share Pharmaceutical Investing
Jamieson Wellness Inc. Announces Voting Results from 2023 Annual and Special Meeting of Shareholders Life Science Investing News
New Clinical Study Suggests the Use of OraPharma's ARESTIN Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis Pharmaceutical Investing
U.S. District Court Upholds Final Judgment for XIFAXAN 550 mg That Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029 Pharmaceutical Investing
Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia Pharmaceutical Investing
